Law360, New York (June 05, 2009, 12:00 AM ET) -- Actavis Group, the pharmaceutical company at the center of a storm over the recalled heart medication Digitek, has asked a federal judge to modify or quash a subpoena served on Gibraltar Laboratories Inc., saying the subpoena asks Gibraltar to turn over information unrelated to the drug at issue.
Actavis filed the motion Thursday in the U.S. District Court for the Southern District of West Virginia, arguing that the plaintiffs' subpoena sought too broad an array of information from Gibraltar, a nonparty in the case that provides...
Actavis Seeks To Narrow Subpoena In Digitek MDL
To view the full article, take a free trial now.
